Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

583 Articles

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2018 at 10:15 AM EDT

AbbVie Slumps on Late-Stage Lymphoma Trial

AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.

Chris Lange | Jul 7, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on July’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jun 15, 2018 at 10:07 AM EDT

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Lee Jackson | Jun 1, 2018 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines…

Lee Jackson | May 30, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Apple, Broadcom, Exxon Mobil, Fabrinet, HP, Match…

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 1, 2018 at 10:50 AM EDT

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Apr 22, 2018 at 10:15 AM EDT

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 19 20 21 22 23 … 39

AbbVie : ABBV

All AbbVie Articles

Where Did Major Pharma Short Sellers Go?

AbbVie Slumps on Late-Stage Lymphoma Trial

Major Biopharma Catalysts on July’s FDA Calendar

Short Sellers Hike Bets in Major Pharma Stocks

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

AbbVie : ABBV

All AbbVie Articles

Where Did Major Pharma Short Sellers Go?

AbbVie Slumps on Late-Stage Lymphoma Trial

Major Biopharma Catalysts on July’s FDA Calendar

Short Sellers Hike Bets in Major Pharma Stocks

Big Pharmaceuticals Stocks May Be The Safest Place To Be Now

Major Pharmaceuticals Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Dana, Humana, International Paper, Navistar, Southwest Airlines, Tesla and More

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Broadcom, Exxon, Fabrinet, HP, Match, Target and More

Major Pharma Short Sellers Grow More Selective

Short Sellers Run for Cover From Major Pharma

Why One Old Stock Buyback Trick Is Working So Well for AbbVie

Short Sellers Grow More Selective on Major Pharma Stocks

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

The Major Pharma Stocks That Are Making Short Sellers Sick

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation